Difference between revisions of "Proton pump inhibitor effect"
Jump to navigation
Jump to search
Line 8: | Line 8: | ||
**Used to treat [[gastroesophageal reflux disease]]. | **Used to treat [[gastroesophageal reflux disease]]. | ||
Some proton pump inhibitors | ===Some proton pump inhibitors=== | ||
{| class="wikitable sortable" | |||
! Generic name | |||
! Brand name(s) | |||
|- | |||
|Omeprazole | |||
|LOSEC | |||
|- | |||
|Dexlansoprazole | |||
|DEXILANT | |||
|- | |||
|Lansoprazole | |||
|PREVACID | |||
|- | |||
|Esomeprazole | |||
|NEXIUM | |||
|- | |||
|Pantoprazole | |||
|PANTOLOC | |||
|- | |||
|Rabeprazole | |||
|PARIET | |||
|} | |||
==Microscopic== | ==Microscopic== |
Revision as of 02:03, 3 February 2014
Proton pump inhibitor effect, abbreviated PPI effect, is a change seen in the parietal cells of the stomach due to a drug in the proton pump inhibitor class.
Formally, it is stomach with proton pump inhibitor effect.
General
- Due to intake of a proton pump inhibitor (PPI).
- Used to treat gastroesophageal reflux disease.
Some proton pump inhibitors
Generic name | Brand name(s) |
---|---|
Omeprazole | LOSEC |
Dexlansoprazole | DEXILANT |
Lansoprazole | PREVACID |
Esomeprazole | NEXIUM |
Pantoprazole | PANTOLOC |
Rabeprazole | PARIET |
Microscopic
Features:[1]
- Parietal cell enlargement - key feature.
- Parietal cells typically bulge into the lumen.
Images
www:
Sign out
- Usually not reported.